160 related articles for article (PubMed ID: 9489852)
1. The effects of nicotine on dopamine and DOPAC output from rat striatal tissue.
Dluzen DE; Anderson LI
Eur J Pharmacol; 1998 Jan; 341(1):23-32. PubMed ID: 9489852
[TBL] [Abstract][Full Text] [Related]
2. The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats.
Dluzen DE; Liu B
J Neural Transm Gen Sect; 1994; 95(3):209-22. PubMed ID: 7865176
[TBL] [Abstract][Full Text] [Related]
3. S(-)-nornicotine increases dopamine release in a calcium-dependent manner from superfused rat striatal slices.
Dwoskin LP; Buxton ST; Jewell AL; Crooks PA
J Neurochem; 1993 Jun; 60(6):2167-74. PubMed ID: 8492124
[TBL] [Abstract][Full Text] [Related]
4. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
[TBL] [Abstract][Full Text] [Related]
5. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
Xu K; Dluzen DE
J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
[TBL] [Abstract][Full Text] [Related]
6. Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants.
Dopheide MM; Morgan RE; Rodvelt KR; Schachtman TR; Miller DK
Eur J Pharmacol; 2007 Jul; 568(1-3):112-23. PubMed ID: 17477916
[TBL] [Abstract][Full Text] [Related]
7. Release of endogenous dopamine, 3,4-dihydroxyphenylacetic acid, and amino acid transmitters from rat striatal slices.
Flint RS; Murphy JM; McBride WJ
Neurochem Res; 1985 Apr; 10(4):515-27. PubMed ID: 2860579
[TBL] [Abstract][Full Text] [Related]
8. Nicotine and amphetamine acutely cross-potentiate their behavioral and neurochemical responses in female Holtzman rats.
Jutkiewicz EM; Nicolazzo DM; Kim MN; Gnegy ME
Psychopharmacology (Berl); 2008 Sep; 200(1):93-103. PubMed ID: 18566803
[TBL] [Abstract][Full Text] [Related]
9. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
10. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats.
Pierce RC; Rebec GV
Brain Res; 1992 May; 579(1):59-66. PubMed ID: 1352478
[TBL] [Abstract][Full Text] [Related]
12. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
[TBL] [Abstract][Full Text] [Related]
13. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC.
Zetterström T; Sharp T; Collin AK; Ungerstedt U
Eur J Pharmacol; 1988 Apr; 148(3):327-34. PubMed ID: 3384000
[TBL] [Abstract][Full Text] [Related]
14. The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation.
Xu K; Dluzen DE
Exp Neurol; 2000 Dec; 166(2):450-7. PubMed ID: 11085910
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of inorganic mercury (HgCl(2)) on striatal dopaminergic system.
Faro LR; do Nascimento JL; Alfonso M; Durán R
Ecotoxicol Environ Saf; 2001 Mar; 48(3):263-7. PubMed ID: 11222035
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
17. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
18. Intermittent infusion of progesterone potentiates whereas continuous infusion reduces amphetamine-stimulated dopamine release from ovariectomized estrogen-primed rat striatal fragments superfused in vitro.
Dluzen DE; Ramirez VD
Brain Res; 1987 Mar; 406(1-2):1-9. PubMed ID: 3567619
[TBL] [Abstract][Full Text] [Related]
19. The importance of striatal interneurons in age-related effects upon potassium- and amphetamine-stimulated dopamine release.
Dluzen DE; Laping NJ; Ramirez VD
Brain Res; 1988 Apr; 445(2):354-7. PubMed ID: 3370468
[TBL] [Abstract][Full Text] [Related]
20. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
Clarke PB; Reuben M
Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
